Analysed HARROW INC (HROW:NASDAQ) News Sources
Harrow Acquires Global Rights to TYRVAYA®, the First and Only FDA-Approved Nasal Spray for Dry Eye Disease
06-08-2026
yahoo.com
Harrow Announces IHEEZO® Data in Patient-Reported Discomfort Following Intravitreal Injections
20-08-2026
yahoo.com
Harrow Inc (HROW) (Q2 2026) Earnings Call Highlights: Record Demand and Strategic Expansion ...
11-08-2026
yahoo.com
Viatris (VTRS) is Selling Tyrvaya, but Could Harrow (HROW) Turn it Into a Growth Engine?
13-08-2026
yahoo.com
What is the current price of HARROW INC (HROW:NASDAQ)?
The current price of HARROW INC (HROW:NASDAQ) is $34.48.
HARROW INC (HROW:NASDAQ) absolute price change since previous trading day?
The absolute price change of HARROW INC (HROW:NASDAQ) since the previous trading day is $-2.1.
HARROW INC (HROW:NASDAQ) percentage price change since previous trading day?
The percentage price change of HARROW INC (HROW:NASDAQ) since the previous trading day is -5.7408%.
What is the most recent average sentiment score for HARROW INC (HROW:NASDAQ)?
The most recent average sentiment score for HARROW INC (HROW:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for HARROW INC (HROW:NASDAQ)?
The most recent sentiment for HARROW INC (HROW:NASDAQ) is .
SEC-8K** Filing Available For HARROW INC (HROW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.